BGI Genomics Co., Ltd. — Investor Relations & Filings
BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于延长公司2020年面向合格投资者公开发行公司债券（第一期）簿记建档时间的公告 | 2020-04-23 | Chinese | |
| 关于面向合格投资者公开发行公司债券更名公告 | 2020-04-21 | Chinese | |
| 2020年面向合格投资者公开发行公司债券（第一期）募集说明书 | 2020-04-21 | Chinese | |
| 2020年面向合格投资者公开发行公司债券（第一期）发行公告 | 2020-04-21 | Chinese | |
| 2020年面向合格投资者公开发行公司债券（第一期）信用评级报告 | 2020-04-21 | Chinese | |
| 2020年面向合格投资者公开发行公司债券（第一期）募集说明书摘要 | 2020-04-21 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 38350738 | 关于延长公司2020年面向合格投资者公开发行公司债券（第一期）簿记建档时间的公告 | 2020-04-23 | Chinese | ||
| 38350720 | 关于面向合格投资者公开发行公司债券更名公告 | 2020-04-21 | Chinese | ||
| 38350701 | 2020年面向合格投资者公开发行公司债券（第一期）募集说明书 | 2020-04-21 | Chinese | ||
| 38350534 | 2020年面向合格投资者公开发行公司债券（第一期）发行公告 | 2020-04-21 | Chinese | ||
| 38350503 | 2020年面向合格投资者公开发行公司债券（第一期）信用评级报告 | 2020-04-21 | Chinese | ||
| 38350317 | 2020年面向合格投资者公开发行公司债券（第一期）募集说明书摘要 | 2020-04-21 | Chinese | ||
| 38350201 | 关于新型冠状病毒检测试剂盒销售相关网络传闻的澄清公告 | 2020-04-16 | Chinese | ||
| 38350195 | 关于全资子公司产品获得澳大利亚TGA注册的公告 | 2020-04-14 | Chinese | ||
| 38350189 | 2020年第一季度业绩预告 | 2020-04-09 | Chinese | ||
| 38350179 | 2020年第三次临时股东大会之法律意见书 | 2020-04-02 | Chinese | ||
| 38350165 | 2020年第三次临时股东大会决议公告 | 2020-04-02 | Chinese | ||
| 38350158 | 关于控股股东一致行动人部分股份解除质押及再质押的公告 | 2020-04-01 | Chinese | ||
| 38350144 | 关于全资子公司产品通过日本PMDA认证的公告 | 2020-04-01 | Chinese | ||
| 38350138 | 关于召开2020年第三次临时股东大会的提示性公告 | 2020-03-30 | Chinese | ||
| 38350120 | 关于海外新型冠状病毒检测相关媒体报道的澄清公告 | 2020-03-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BGI Genomics Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55655/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55655 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55655 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55655 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55655}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BGI Genomics Co., Ltd. (id: 55655)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.